Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

493 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effect of different human papillomavirus serological and DNA criteria on vaccine efficacy estimates.
Lang Kuhs KA, Porras C, Schiller JT, Rodriguez AC, Schiffman M, Gonzalez P, Wacholder S, Ghosh A, Li Y, Lowy DR, Kreimer AR, Poncelet S, Schussler J, Quint W, van Doorn LJ, Sherman ME, Sidawy M, Herrero R, Hildesheim A, Safaeian M; Costa Rica Vaccine Trial Group. Lang Kuhs KA, et al. Among authors: sherman me. Am J Epidemiol. 2014 Sep 15;180(6):599-607. doi: 10.1093/aje/kwu168. Epub 2014 Aug 19. Am J Epidemiol. 2014. PMID: 25139208 Free PMC article. Clinical Trial.
A comparison of single and combined visual, cytologic, and virologic tests as screening strategies in a region at high risk of cervical cancer.
Ferreccio C, Bratti MC, Sherman ME, Herrero R, Wacholder S, Hildesheim A, Burk RD, Hutchinson M, Alfaro M, Greenberg MD, Morales J, Rodriguez AC, Schussler J, Eklund C, Marshall G, Schiffman M. Ferreccio C, et al. Among authors: sherman me. Cancer Epidemiol Biomarkers Prev. 2003 Sep;12(9):815-23. Cancer Epidemiol Biomarkers Prev. 2003. PMID: 14504189
Seroreactivity to human papillomavirus (HPV) types 16, 18, or 31 and risk of subsequent HPV infection: results from a population-based study in Costa Rica.
Viscidi RP, Schiffman M, Hildesheim A, Herrero R, Castle PE, Bratti MC, Rodriguez AC, Sherman ME, Wang S, Clayman B, Burk RD. Viscidi RP, et al. Among authors: sherman me. Cancer Epidemiol Biomarkers Prev. 2004 Feb;13(2):324-7. doi: 10.1158/1055-9965.epi-03-0166. Cancer Epidemiol Biomarkers Prev. 2004. PMID: 14973086
Description of a seven-year prospective study of human papillomavirus infection and cervical neoplasia among 10000 women in Guanacaste, Costa Rica,
Bratti MC, Rodríguez AC, Schiffman M, Hildesheim A, Morales J, Alfaro M, Guillén D, Hutchinson M, Sherman ME, Eklund C, Schussler J, Buckland J, Morera LA, Cárdenas F, Barrantes M, Pérez E, Cox TJ, Burk RD, Herrero R. Bratti MC, et al. Among authors: sherman me. Rev Panam Salud Publica. 2004 Feb;15(2):75-89. doi: 10.1590/s1020-49892004000200002. Rev Panam Salud Publica. 2004. PMID: 15030652
Validation of p16INK4a as a marker of oncogenic human papillomavirus infection in cervical biopsies from a population-based cohort in Costa Rica.
Wang SS, Trunk M, Schiffman M, Herrero R, Sherman ME, Burk RD, Hildesheim A, Bratti MC, Wright T, Rodriguez AC, Chen S, Reichert A, von Knebel Doeberitz C, Ridder R, von Knebel Doeberitz M. Wang SS, et al. Among authors: sherman me. Cancer Epidemiol Biomarkers Prev. 2004 Aug;13(8):1355-60. Cancer Epidemiol Biomarkers Prev. 2004. PMID: 15298958
493 results